CCR5 detection of peripheral blood mononuclear cells from AD patients and healthy controls; Peripheral intravenous injection of Aβ in rats, followed by administration of CCR5 CCR5 antagonist (2D7 mAb). This evidence concerns the gene CCR5 and Alzheimer disease.